Purity matters because consistency does: what a variable input costs a CPG line

Purity is usually argued as a quality point, which is why it rarely lands with a manufacturer. Quality is table stakes. The argument that actually matters is narrower and more practical: an input that varies between batches forces work downstream, and that work is what has kept large-scale formulators out of this category.

The problem isn't the 90%. It's the rest.

Legacy distillation puts purity at just over 90%. The number itself is not the difficulty — plenty of industrial inputs sit lower and cause nobody trouble. The difficulty is that the remaining fraction is not well characterised, and it is not the same fraction twice.

What is in it depends on the input material and on what distillation did to it: isomers of Δ9-THC formed during processing, lipids carried through from the plant, degradants that accumulate over time, and material introduced by the extraction itself. Different flower, different run, different remainder.

A characterised impurity is a formulation input. An uncharacterised one is a variable.

What variance actually costs on a line

The impurity profile is what a formulator ends up managing, and it shows up first in flavour — which matters most precisely where cannabis-infused products are hardest to make well, in beverages and edibles. The standard response is to mask it: sugar, substitutes, added flavours.

That works, but it is a moving target. Because the impurities vary between batches, the masking has to vary too. And once the formulation is moving, everything attached to it moves: production time extends, raw material quantities fluctuate, labels churn, and every change is a compliance question rather than a preference.

None of those costs appear in a purity specification. All of them appear in a manufacturing schedule.

Why this is a barrier to entry, not just an annoyance

A CPG manufacturer operating at industrial scale is not optimising for the best possible batch. They are optimising for the batch after next being identical to this one — because that is what brand consistency, automation and supply agreements are all built on.

An input that cannot promise that does not merely make the work harder. It makes the category unenterable, because the thing being asked for — reliable sameness — is the one thing the input cannot supply. That, rather than any single quality metric, is the substantive obstacle.

Manufacturers aren't asking for the best material. They're asking for the same material.

What high purity actually removes

Isolating THCa to purity approaching 100% and decarboxylating it under controlled conditions produces material whose composition is known and repeatable. The gain is not a better number on a certificate. It is that there is no longer a variable fraction to manage — nothing to mask, nothing to re-verify batch by batch, nothing to reformulate around.

Consistent, characterized material drops into existing recipes, existing lines and existing supply chains. And because the documentation is generated as the work happens — batch records, release testing, a certificate per batch — what a quality team needs during qualification already exists rather than having to be constructed after the fact.

The claim, stated plainly

Purity matters because consistency matters, and consistency is what makes industrial-scale formulation possible at all. Everything else — simpler formulation, fewer additives, steadier logistics, cleaner audits — follows from having removed the variance rather than having learned to live with it.